Publikationen in Zusammenarbeit mit Forschern von Addenbrooke's Hospital (37)

2017

  1. Physical activity, mediating factors and risk of colon cancer: Insights into adiposity and circulating biomarkers from the EPIC cohort

    International Journal of Epidemiology, Vol. 46, Núm. 6, pp. 1823-1835

  2. Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Serum endotoxins and flagellin and risk of colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC) cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 2, pp. 291-301

2015

  1. Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study

    PLoS Medicine, Vol. 12, Núm. 6

  2. Plasma elaidic acid level as biomarker of industrial trans fatty acids and risk of weight change: Report from the EPIC study

    PLoS ONE, Vol. 10, Núm. 2

  3. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: Data from the European Prospective Investigation into Cancer and Nutrition

    American Journal of Clinical Nutrition, Vol. 102, Núm. 6, pp. 1498-1508

2014

  1. Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

    Hepatology, Vol. 60, Núm. 3, pp. 858-871

  2. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

    Blood, Vol. 124, Núm. 4, pp. 530-535

  3. Prediagnostic telomere length and risk of B-cell lymphoma-results from the epic cohort study

    International Journal of Cancer, Vol. 135, Núm. 12, pp. 2910-2917

2013

  1. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

    International Journal of Cancer, Vol. 132, Núm. 3, pp. 645-657

  2. Age at menarche and type 2 diabetes risk: The EPIC-InterAct study

    Diabetes Care, Vol. 36, Núm. 11, pp. 3526-3534

  3. Age at menopause, reproductive life span, and type 2 diabetes risk: Results from the EPIC-InterAct study

    Diabetes Care, Vol. 36, Núm. 4, pp. 1012-1019

  4. Challenges in estimating the validity of dietary acrylamide measurements

    European Journal of Nutrition, Vol. 52, Núm. 5, pp. 1503-1512

  5. Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European prospective investigation into cancer and nutrition study

    American Journal of Clinical Nutrition, Vol. 97, Núm. 2, pp. 344-353

  6. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Annals of Oncology, Vol. 24, Núm. 10, pp. 2645-2651

  7. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: Results from the EPIC cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 22, Núm. 11, pp. 2056-2065

2012

  1. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: A large prospective cohort study

    Breast Cancer Research, Vol. 14, Núm. 3

  2. Alcohol consumption and risk of type 2 diabetes in European men and women: Influence of beverage type and body sizeThe EPIC-InterAct study

    Journal of Internal Medicine, Vol. 272, Núm. 4, pp. 358-370

  3. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

    American Journal of Clinical Nutrition, Vol. 96, Núm. 2, pp. 345-355

  4. Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis

    European Journal of Clinical Nutrition, Vol. 66, Núm. 10, pp. 1082-1092